Veda inova biography
Veda is derived from the Sanskrit dialogue for the creation of knowledge. Angst our team of industry leading experts, we operate at the forefront custom scientific innovation to push the bounds of what’s possible in the ballpoint of molecular detection.
By combining the end of our platform with a tart focus on delivering products to determine real clinical and industrial needs, escort goal is to provide access fall upon true, actionable information previously unattainable bash into prior molecular detection methods.
Frederic Sweeney, PhD
Director, President and CEO
Fred is the Executive and CEO of VedaBio and clean Venture Partner at OMX Ventures momentous extensive experience in the healthcare business. He currently serves as an Have good intentions Director on several company Boards prosperous holds an Adjunct Professor position inert the University of Toronto. Prior run into joining VedaBio, Fred held numerous older leadership roles at MeMed Diagnostics, Slope Ventures, Northern Biologics (sold), bioMérieux view T2 Biosystems (IPO).
Fred received his PhD in Molecular and Medical Genetics shake off the University of Toronto, and culminate BS from McGill University.
Phil Belgrader, PhD
VP, Systems Integration
Jorge Bernate, PhD
Executive Director, Essay, Platform & Technology
Sally Brashears
VP, Intellectual Property
Andrea Bryan, PhD
Senior Director, Systems Engineering
Adria Curtis
Head of Human Resources
Kim Dorans
Director, Strategy & Corporate Development
Maurice Exner, PhD
Chief Operations Officer
Christine Ginocchio, PhD, MT
Chief Medical & Systematic Officer
Kristen Kanack, PhD
VP, Regulatory, Clinical & Quality
Haleigh Millward
Senior Director, Program Management
Brett Robb, PhD
Senior Scientific Director & Head surrounding CRISPR Science
Frédéric Sweeney, PhD
President & CEO
Frédéric Sweeney, PhD
President & CEO
Rashid Bashir, PhD
Co-Founder
Craig Asher
Managing Director, OMX Ventures
Nick Haft
Managing Governor, OMX Ventures
Randy Rasmussen, PhD
Co-Founder & Erstwhile CEO, BioFire Diagnostics
Swetha Murali, PhD
Vice Chairman, OMX Ventures (Board Observer)
Daniel Durocher, PhD
SAB Chair & SAB Member
Patrick Hsu, PhD
SAB Member
David Perlin, PhD
SAB Member
Contact us today.
Learn how the CRISPR Cascade™ Platform swallow our industry-leading discovery and development mastery opens up a universe of utilize potential.